Isoniazid drug and food interactions
- PMID: 10334118
- DOI: 10.1097/00000441-199905000-00007
Isoniazid drug and food interactions
Abstract
Isoniazid inhibits the metabolism of several drugs, resulting in clinically significant interactions in some patients. Clinical trials and case reports have documented that isoniazid can cause increased phenytoin and carbamazepine serum concentrations and toxicity. In relatively high doses, isoniazid can also cause increased effect of theophylline and warfarin. Isoniazid inhibits metabolism of selected benzodiazepines and vitamin D. Inhibition of monoamine oxidase and histaminase by isoniazid can cause significant drug-food interactions. Food greatly decreases isoniazid bioavailability. Although probably best recognized as an inhibitor of drug metabolism, isoniazid has a biphasic effect of inhibition-induction on one cytochrome P450 isozyme, CYP2E1, which partially explains the interaction with acetaminophen and increased risk of hepatotoxicity. Continued investigations will likely result in discovery of new isoniazid interactions.
Similar articles
-
Isoniazid interactions.South Med J. 1985 Jun;78(6):714-8. doi: 10.1097/00007611-198506000-00025. South Med J. 1985. PMID: 3890202 Review.
-
Pharmacokinetic drug interactions with oral contraceptives.Clin Pharmacokinet. 1990 Jun;18(6):472-84. doi: 10.2165/00003088-199018060-00004. Clin Pharmacokinet. 1990. PMID: 2191822 Review.
-
Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles.Int J Pharm. 2013 Jan 30;441(1-2):202-12. doi: 10.1016/j.ijpharm.2012.11.042. Epub 2012 Dec 5. Int J Pharm. 2013. PMID: 23220081
-
Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids.Int J Tuberc Lung Dis. 1999 Aug;3(8):703-10. Int J Tuberc Lung Dis. 1999. PMID: 10460103 Clinical Trial.
-
Pharmacogenetics of isoniazid-induced hepatotoxicity.Drug Metab Rev. 2015 May;47(2):222-8. doi: 10.3109/03602532.2014.984070. Epub 2014 Nov 19. Drug Metab Rev. 2015. PMID: 26095714 Review.
Cited by
-
Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.Pharmacol Ther. 2012 Nov;136(2):186-201. doi: 10.1016/j.pharmthera.2012.08.001. Epub 2012 Aug 4. Pharmacol Ther. 2012. PMID: 22884524 Free PMC article. Review.
-
Clinical significance of the cytochrome P450 2C19 genetic polymorphism.Clin Pharmacokinet. 2002;41(12):913-58. doi: 10.2165/00003088-200241120-00002. Clin Pharmacokinet. 2002. PMID: 12222994 Review.
-
Integration of Clinical and Scientific Principles in the Teaching of Drug-Drug Interactions.Med Sci Educ. 2021 Sep 10;31(6):2169-2176. doi: 10.1007/s40670-021-01395-8. eCollection 2021 Dec. Med Sci Educ. 2021. PMID: 34956730 Free PMC article.
-
Hepatotoxic effects of therapies for tuberculosis.Nat Rev Gastroenterol Hepatol. 2010 Oct;7(10):543-56. doi: 10.1038/nrgastro.2010.134. Epub 2010 Aug 31. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20808293 Review.
-
Chemotherapy of Tuberculosis.Microbiol Spectr. 2017 Apr;5(2):10.1128/microbiolspec.tnmi7-0040-2017. doi: 10.1128/microbiolspec.TNMI7-0040-2017. Microbiol Spectr. 2017. PMID: 28387179 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources